scholarly journals Correction: Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism

2019 ◽  
Vol 79 (8) ◽  
pp. 2084-2084
Author(s):  
Camila M. Lopes-Ramos ◽  
Marieke L. Kuijjer ◽  
Shuji Ogino ◽  
Charles S. Fuchs ◽  
Dawn L. DeMeo ◽  
...  
2018 ◽  
Vol 78 (19) ◽  
pp. 5538-5547 ◽  
Author(s):  
Camila M. Lopes-Ramos ◽  
Marieke L. Kuijjer ◽  
Shuji Ogino ◽  
Charles S. Fuchs ◽  
Dawn L. DeMeo ◽  
...  

2018 ◽  
Author(s):  
Camila M. Lopes-Ramos ◽  
Marieke L. Kuijjer ◽  
Shuji Ogino ◽  
Charles Fuchs ◽  
Dawn L. DeMeo ◽  
...  

AbstractSignificant sex differences are observed in colon cancer, and understanding these differences is essential to advance disease prevention, diagnosis, and treatment. Males have a higher risk of developing colon cancer and a lower survival rate than women. However, the molecular features that drive these sex differences are poorly understood. We used both transcript-based and gene regulatory network methods to analyze RNA-Seq data from The Cancer Genome Atlas for 445 patients with colon cancer. We compared gene expression between tumors in men and women and found no significant sex differences except for sex-chromosome genes. We then inferred patient-specific gene regulatory networks, and found significant regulatory differences between males and females, with drug and xenobiotics metabolism via cytochrome P450 pathways more strongly targeted in females. This finding was validated in a dataset that included 1,193 patients from five independent studies. While targeting of the drug metabolism pathway did not change the overall survival for males treated with adjuvant chemotherapy, females with greater targeting had an increase in 10-year overall survival probability, with 89% (95% CI: 78%-100%) survival compared to 61% (95% CI: 45%-82%) for women with lower targeting, respectively (p=0.034). Our network analysis uncovered patterns of transcriptional regulation that differentiate male and female colon cancer. Most importantly, targeting of the drug metabolism pathway was predictive of survival in women who received adjuvant chemotherapy. This network-based approach can be used to investigate the molecular features that drive sex differences in other cancers and complex diseases.


2020 ◽  
pp. 1052-1075 ◽  
Author(s):  
Dina Elsayad ◽  
A. Ali ◽  
Howida A. Shedeed ◽  
Mohamed F. Tolba

The gene expression analysis is an important research area of Bioinformatics. The gene expression data analysis aims to understand the genes interacting phenomena, gene functionality and the genes mutations effect. The Gene regulatory network analysis is one of the gene expression data analysis tasks. Gene regulatory network aims to study the genes interactions topological organization. The regulatory network is critical for understanding the pathological phenotypes and the normal cell physiology. There are many researches that focus on gene regulatory network analysis but unfortunately some algorithms are affected by data size. Where, the algorithm runtime is proportional to the data size, therefore, some parallel algorithms are presented to enhance the algorithms runtime and efficiency. This work presents a background, mathematical models and comparisons about gene regulatory networks analysis different techniques. In addition, this work proposes Parallel Architecture for Gene Regulatory Network (PAGeneRN).


2020 ◽  
Author(s):  
Masahiro Nogami ◽  
Mitsuru Ishikawa ◽  
Atsushi Doi ◽  
Osamu Sano ◽  
Takefumi Sone ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. e37833 ◽  
Author(s):  
Haisun Zhu ◽  
Rajanikanth Vadigepalli ◽  
Rachel Rafferty ◽  
Gregory E. Gonye ◽  
David R. Weaver ◽  
...  

Agri Gene ◽  
2017 ◽  
Vol 3 ◽  
pp. 37-45 ◽  
Author(s):  
Swati Srivastava ◽  
Noopur Singh ◽  
Gaurava Srivastava ◽  
Ashok Sharma

Author(s):  
Manasa KP ◽  
Darius Wlochowitz ◽  
Edgar Wingender ◽  
Tim Beißbarth ◽  
ALEXANDER KEL

Only two percent of Glioblastoma multiforme (GBM) patients respond to standard care and survive beyond 36 months (long-term survivors, LTS) while the majority survives less than 12 months (short-term survivors, STS). To understand the mechanism leading to poor survival, we analyzed publicly available datasets of 113 STS and 58 LTS. This analysis revealed 198 differentially expressed genes (DEGs) that co-occur with aggressive tumor growth and may be responsible for the poor prognosis. These genes belong largely to the GO-categories “epithelial to mesenchymal transition” and “response to hypoxia”. In this paper we applied upstream analysis approach which involves state-of-art promoter analysis and network analysis of the dysregulated genes potentially responsible for short survival in GBM. Transcription factors associated with GBM pathology like NANOG, NF-κB, REST, FRA-1, PPARG and seven others were found enriched in regulatory regions of the dysregulated genes. Based on network analysis, we propose novel gene regulatory network regulated by five master regulators – IGFBP2, VEGFA, VEGF165, PDGFA, AEBP1 and OSMR which can potentially act as therapeutic targets for enhancing GBM prognosis. Critical analysis of this gene regulatory network gives insights on mechanism of gene regulation by IGFBP2 via several transcription factors including the key molecule of GBM tumor invasiveness and progression FRA-1. All the observations are validated in independent cohorts and their impact on overall is studied on TCGA-GBM RNA seq data.


Sign in / Sign up

Export Citation Format

Share Document